Are hot flashes a warning sign?

Menopausal hot flashes and night sweats, called vasomotor symptoms, are linked in research to higher odds of dementia and cardiovascular disease. But studies don’t necessarily account for other health and lifestyle factors that influence brain and heart health. Women who are physically active and have a lower body mass index are less likely to become cognitively impaired. Disrupted sleep, which is common for women with vasomotor symptoms, may also contribute to cardiovascular and cognitive problems.

Content restricted. Requires subscription

Burning mouth syndrome: The scorching reality

Burning mouth syndrome affects about 2% of people, with women up to seven times more likely than men to be diagnosed. Symptoms include burning sensations in the lips, mouth, or throat as well as stabbing pain, tingling, a sour or metallic taste, or the sense that something is crawling inside the mouth. Women’s hormone dips during perimenopause and beyond may play a role in the condition, and stress and anxiety are also considered risk factors. To confirm the diagnosis, doctors must first rule out other potential causes of symptoms.

Content restricted. Requires subscription

Is it really GERD?

In gastroesophageal reflux disease (GERD), stomach acid washes backward into the esophagus. This can cause symptoms such as heartburn, an acidic or metallic taste in the mouth, hoarse voice, chest pain, dry cough, post-nasal drip, or trouble swallowing. Symptoms can overlap with those of several other conditions. These include hiatal hernia, functional dyspepsia, eosinophilic esophagitis, esophageal spasms, or heart attack. Distinguishing GERD from other conditions may involve various tests, including an endoscopy to view the esophagus lining.

Content restricted. Requires subscription

Second-guessing symptoms

While many health symptoms resolve quickly on their own, others linger and make people wonder if they need to see a doctor. Symptoms that warrant a doctor’s visit include drawn-out cold symptoms such as fatigue, cough, and low-grade fever; a fever lasting more than four days; unexpected symptoms when starting a new medication or after surgery; certain digestive problems; and new or worsening mental health issues.

Content restricted. Requires subscription

A new approach to peripheral artery disease

A 2025 randomized controlled trial found that GLP-1 receptor agonists, the blockbuster drugs approved to treat diabetes and obesity, boosted the walking ability of people with diabetes and peripheral artery disease (PAD) in the legs. The news is encouraging, since there are few effective treatments for PAD—reduced blood flow in the limbs that leads to pain with activity. However, it will take more evidence before doctors feel comfortable prescribing GLP-1s if a person only has PAD.

Content restricted. Requires subscription